PHARMACYTE BIOTECH, INC. Shareholders' Equity
PHARMACYTE BIOTECH, INC. (PMCB) had Shareholders' Equity of $27.51 million as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-14
- 2026-07-31: Stockholders' Equity Attributable to Parent $27.51M.
- 2026-04-30: Stockholders' Equity Attributable to Parent $33.29M.
- 2026-01-31: Stockholders' Equity Attributable to Parent $38.11M.
- 2025-10-31: Stockholders' Equity Attributable to Parent $35.24M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-07-31 | $27.51M 10-Q · filed 2026-09-14 | |
| 2026-04-30 | $33.29M 10-Q · filed 2026-09-14 | |
| 2026-01-31 | $38.11M 10-Q · filed 2026-03-17 | |
| 2025-10-31 | $35.24M 10-Q · filed 2026-03-17 | |
| 2025-07-31 | $43.59M 10-Q · filed 2026-09-14 | |
| 2025-04-30 | $51.89M 10-Q · filed 2026-09-14 | |
| 2025-01-31 | $40.25M 10-Q · filed 2026-03-17 | |
| 2024-10-31 | $43.45M 10-Q · filed 2026-03-17 | |
| 2024-07-31 | $47.71M 10-Q · filed 2026-03-17 | |
| 2024-04-30 | $27.65M 10-K · filed 2026-07-29 | |
| 2024-01-31 | $31.37M 10-Q · filed 2025-03-17 | |
| 2023-10-31 | $36.77M 10-Q · filed 2025-03-17 | |
| 2023-07-31 | $39.19M 10-Q · filed 2025-03-17 | $42.73M 10-Q · filed 2023-09-18 |
| 2023-04-30 | $72.69M 10-K · filed 2025-08-11 | |
| 2023-01-31 | $77.12M 10-Q · filed 2024-03-18 | |
| 2022-10-31 | $81.04M 10-Q · filed 2024-03-18 | |
| 2022-07-31 | $86.30M 10-Q · filed 2024-03-18 | |
| 2022-04-30 | $89.92M 10-K · filed 2024-08-13 | |
| 2022-01-31 | $91.33M 10-Q · filed 2023-03-16 | |
| 2021-10-31 | $92.12M 10-Q · filed 2023-03-16 | |
| 2021-07-31 | $5.71M 10-Q · filed 2023-03-16 | |
| 2021-04-30 | $6.68M 10-K · filed 2023-07-31 | |
| 2021-01-31 | $7.61M 10-Q · filed 2022-03-15 | |
| 2020-10-31 | $8.28M 10-Q · filed 2022-03-15 | |
| 2020-07-31 | $6.25M 10-Q · filed 2022-03-15 | |
| 2020-04-30 | $5.09M 10-K · filed 2022-07-28 | |
| 2020-01-31 | $4.32M 10-Q · filed 2021-03-12 | |
| 2019-10-31 | $4.53M 10-Q · filed 2021-03-12 | |
| 2019-07-31 | $5.00M 10-Q · filed 2021-03-12 | |
| 2019-04-30 | $5.04M 10-K · filed 2021-08-10 | |
| 2019-01-31 | $5.37M 10-Q · filed 2020-03-13 | |
| 2018-10-31 | $5.40M 10-Q · filed 2020-03-13 | |
| 2018-07-31 | $6.20M 10-Q · filed 2020-03-13 | |
| 2018-04-30 | $5.77M 10-K · filed 2020-08-13 | |
| 2018-01-31 | $5.84M 10-Q · filed 2019-03-14 | |
| 2017-10-31 | $7.35M 10-Q · filed 2019-03-14 | |
| 2017-07-31 | $8.66M 10-Q · filed 2019-03-14 | |
| 2017-04-30 | $8.09M 10-K · filed 2019-08-13 | |
| 2017-01-31 | $7.04M 10-Q · filed 2017-03-13 | |
| 2016-10-31 | $6.28M 10-Q · filed 2016-12-02 | |
| 2016-07-31 | $7.07M 10-Q · filed 2016-09-06 | |
| 2016-04-30 | $6.52M 10-K · filed 2018-07-20 | |
| 2016-01-31 | $6.94M 10-Q · filed 2016-03-08 | |
| 2015-10-31 | $6.90M 10-Q/A · filed 2016-01-19 | $6.56M 10-Q · filed 2015-12-10 |
| 2015-07-31 | $7.83M 10-Q/A · filed 2016-01-19 | $6.96M 10-Q · filed 2015-08-25 |
| 2015-04-30 | $7.78M 10-K · filed 2017-07-27 | $5.94M 10-K · filed 2015-07-29 |
| 2015-01-31 | $6.25M 10-Q · filed 2015-03-13 | |
| 2014-10-31 | $6.38M 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $7.83M 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $8.94M 10-K · filed 2016-07-29 | |
| 2014-01-31 | $5.18M 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $3.60M 10-Q · filed 2013-12-16 | |
| 2013-07-31 | $1.90M 10-Q · filed 2013-09-16 | |
| 2013-04-30 | -$1.50M 10-K · filed 2016-07-29 | |
| 2013-01-31 | -$2.03M 10-Q · filed 2013-03-26 | |
| 2012-10-31 | -$2.05M 10-Q · filed 2012-12-26 | |
| 2012-07-31 | -$2.37M 10-Q · filed 2012-09-19 | |
| 2012-04-30 | -$2.28M 10-K/A · filed 2016-01-19 | |
| 2012-01-31 | -$2.25M 10-Q · filed 2012-03-21 | |
| 2011-10-31 | -$2.38M 10-Q · filed 2011-12-15 | |
| 2011-07-31 | -$2.41M 10-Q/A · filed 2011-09-20 | |
| 2011-04-30 | -$2.73M 10-K · filed 2013-07-29 | |
| 2010-04-30 | -$2.45M 10-K · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |